| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.015 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0085 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |